Global Phototherapy Equipment Market 2017-2027

LONDON, September 7, 2017 /PRNewswire/ --

Forecasts by Equipment Type (Conventional, LED-Based, Fibre-Optic), Application (Skin Disease, Neonatal Jaundice), End-User (Hospitals & Clinics, Home Use) and Geography

Phototherapy equipment - our new study reveals trends, R&D progress, and predicted revenues: 

Where is the Phototherapy Equipment market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Discover how to stay ahead: 

Our 146-page report provides 135 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Phototherapy Equipment market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects: 

• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets: 

Along with revenue prediction for the overall world market, there are forecasts for 3 Phototherapy Equipment Types, 2 Phototherapy Applications and 2 Phototherapy End-Users, each forecasted at a global, regional and national level.

Phototherapy Equipment, by Type: 

• Conventional
• LED-Based
• Fibre-Optic

Phototherapy Equipment, by Application: 

• Skin Disease
• Neonatal Jaundice

Phototherapy Equipment, by End-User: 

• Hospitals & Clinics
• Home Use

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 17 leading national markets:

• North America:
• The US
• Canada
• Mexico

• South America:
• Brazil
• Argentina
• Paraguay
• Bolivia
• Rest of South America

• Europe:
• Germany
• The UK
• Italy
• Spain
• France
• Rest of Europe

• APAC:
• Japan
• China
• India
• Australia
• Thailand
• Rest of Asia-Pacific

• RoW:
• Middle East
• Africa
• Other Countries

The report also includes profiles and for some of the leading companies in the Phototherapy market, with a focus on the Phototherapy Equipment segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the Australia in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth: 

Overall world revenue for Phototherapy Equipment will surpass $810m in 2027, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Neurostimulation Market report helps you: 

In summary, our 146-page report provides you with the following knowledge: 

• Revenue forecasts to 2027 for the Neurostimulation market and 3 different segmentations, with forecasts for 3 Equipment Types, 2 Applications and 2 End-Users at a Global, Regional and National level - discover the industry's prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2027 for 6 regional and 17 key national markets - North America, South America, Europe, Asia-Pacific, Middle East and Africa are forecasted, as well as the US, Canada, Mexico, Brazil, Argentina, Bolivia, Paraguay, Germany, France, the UK, Italy, Spain, Japan, China, India, Australia, Thailand

• Discussion of what stimulates and restrains companies and the market 

• Prospects for established firms and those seeking to enter the market - including company profiles for 10 companies involved in the Phototherapy Equipment market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else: 

With our brand new report you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Phototherapy Equipment market and leading companies. You will find data, trends and predictions.

Get our report today Global Phototherapy Equipment Market 2017-2027: Forecasts by Equipment Type (Conventional, LED-Based, Fibre-Optic), Application (Skin Disease, Neonatal Jaundice), End-User (Hospitals & Clinics, Home Use) and Geography.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100.

Or click on https://www.visiongain.com/Report/1985/Global-Phototherapy-Equipment-Market-2017-2027

List of Companies 

Abbott Laboratories

AbbVie, Inc.

Alkermes Plc

Amarin Corp. Plc

Amgen, Inc.

Amnis Corporation

Array BioPharma, Inc.

Associates Of Cape Cod  Inc.

Astex Pharmaceuticals  Inc.

AstraZeneca Plc

ASYMPTOTE LTD

Atom Medical Corporation

Bayer AG

Bayer Corporation

Bayer HealthCare AG

Bayer Schering Pharma Aktiengesellschaft

BioLife Solutions, Inc.

BioMarin Pharmaceutical, Inc.

Biotest AG

Bristol-Myers Squibb Co.

Cardax, Inc.

Cardinal Health, Inc.

Ceapro, Inc.

Celgene Corp.

Cephalon, Inc.

Chugai Pharmaceutical Co., Ltd.

CK Life Sciences International (Holdings), Inc.

Consensys Imaging Service  Inc.

Cornerstone Research & Development  Inc.

Crescendo Bioscience, Inc.

CTI BioPharma Corp.

Deroyal Industries  Inc.

Domain Therapeutics SA

Emd Millipore Corporation

Emd Serono  Inc.

Endo International Plc

European Medicines Agency

Evotec AG

Galderma Sa

GE HEALTHCARE LTD

GlaxoSmithKline Plc

Henry Schein, Inc.

Herbert Waldmann GmbH & Co. KG

Illumina, Inc.

Institut Bergonie

Janssen Biotech, Inc.

JHL Biotech, Inc.

Johnson & Johnson

Laboratoire Theramex

Laboratory Corp. of America Holdings

LifeWatch AG

Lombard Medical, Inc.

Lonza Group AG

McKesson Corp.

Medline Industries  Inc.

Medtronic Plc

Merck KGaA

MorphoSys AG

Motion Picture And Television Fund

Myrexis, Inc.

Myriad Genetics, Inc.

National Biological Corp.

National Cancer Institute

Natus Medical Incorporated

NBTY, Inc.

Neptune Technologies & Bioresources, Inc.

Nexvet Biopharma PLC

nice Neotech Medical Systems Pvt. Ltd.

Northwell Health  Inc.

Novartis AG

OpenLink Financial LLC

Opexa Therapeutics, Inc.

Otsuka Pharmaceutical Co.  Ltd.

Owens & Minor, Inc.

Panacos Pharmaceuticals, Inc.

PELICAN HEALTHCARE LTD

Pfizer Inc.

Pharma Mar SA

Phillips

Phoenix Medical Systems Pvt. Ltd.

Polymer Technology Systems  Inc.

Progyny Inc.

Quanterix Corp.

Quest Diagnostics, Inc.

Smith & Nephew Plc

Spectrum Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

Windtree Therapeutics, Inc.

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com